Reduced factor XII levels in patients with the antiphospholipid syndrome are associated with antibodies to factor XII
Authors:
Open Access
- 1 September 2000
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 110 (3) , 721-726
Abstract
Antibodies to factor XII (FXII) have previously been identified in some patients who were lupus anti‐coagulant‐positive. The relationship between these antibodies and FXII levels appeared to be variable. The aim of the present study was to confirm the presence of antibodies to FXII in patients with well characterized antiphospholipid syndrome (APS) and to establish their potential effect on levels of FXII. Forty‐two patients with APS were studied; 21 patients were found to have either immunoglobulin (Ig)G or IgM antibodies to FXII by enzyme‐linked immunosorbent assay (ELISA) using a highly purified preparation of FXII (> 99% pure). Levels of FXII were statistically significantly lower (P = 0·02) in patients with antibodies to FXII when compared with patients without antibodies to FXII (median = 91 μ/dl, s.d. = 39·1, median = 122 μ/dl, s.d. = 41·1 respectively). Four of the 21 patients with antibodies to FXII were found to have FXII levels below the laboratory normal range. Antibodies to FXII are present in significant numbers of patients with APS and may lead to acquired FXII deficiency.Keywords
This publication has 24 references indexed in Scilit:
- International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshopArthritis & Rheumatism, 1999
- John Hageman's factor and deep‐vein thrombosis: Leiden Thrombophilia StudyBritish Journal of Haematology, 1994
- Immunoelectrophoresis and ELISA techniques for assay of plasma β2 glycoprotein-i and the influence of plasma lipidsThrombosis Research, 1993
- Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo.Journal of Clinical Investigation, 1991
- Anticardiolipin cofactor(s) and differential diagnosis of autoimmune diseaseThe Lancet, 1990
- Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactorThe Lancet, 1990
- Role of the Contact System in FibrinolysisSeminars in Thrombosis and Hemostasis, 1987
- Thrombosis, abortion, cerebral disease, and the lupus anticoagulant.BMJ, 1983
- Thrombosis or Myocardial Infarction in Congenital Clotting Factor Abnormalities and Chronic ThrombocytopeniasMedicine, 1983
- Role of hageman factor in the initiation of clotting by glassThe American Journal of Medicine, 1958